QQ客服 官方微博 反馈留言

	A Randomized Phase II Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Mucosal Melanoma (NCT02023710).
	Chi, Zhihong; Si, Lu; Sheng, Xinan; Cul, Chuanliang; Tang, Bixia; Song, Xin; Zhang, Xiaoshi; Dai, Jie; Kong, Yan; Wang, Xuan
刊名	JOURNAL OF CLINICAL ONCOLOGY
	2016
卷号	34期号:15
ISSN号	0732-183X
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3430451
专题	昆明医科大学
推荐引用方式 GB/T 7714	Chi, Zhihong,Si, Lu,Sheng, Xinan,et al. A Randomized Phase II Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Mucosal Melanoma (NCT02023710).[J]. JOURNAL OF CLINICAL ONCOLOGY,2016,34(15).
APA	Chi, Zhihong.,Si, Lu.,Sheng, Xinan.,Cul, Chuanliang.,Tang, Bixia.,...&Guo, Jun.(2016).A Randomized Phase II Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Mucosal Melanoma (NCT02023710)..JOURNAL OF CLINICAL ONCOLOGY,34(15).
MLA	Chi, Zhihong,et al."A Randomized Phase II Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Mucosal Melanoma (NCT02023710).".JOURNAL OF CLINICAL ONCOLOGY 34.15(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。